Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 63
Filter
1.
Appl Environ Microbiol ; 86(22)2020 10 28.
Article in English | MEDLINE | ID: mdl-32887713

ABSTRACT

The bacterial protease inhibitor domains known as Streptomyces subtilisin inhibitors (SSI) are rarely found in fungi. Genome analysis of a fungal pathogen, Choanephora cucurbitarum KUS-F28377, revealed 11 SSI-like domains that are horizontally transferred and sequentially diverged during evolution. We investigated the molecular function of fungal SSI-like domains of C. cucurbitarum, designated "choanepins." Among the proteins tested, only choanepin9 showed inhibitory activity against subtilisin as the target protease, accounting for 47% of the inhibitory activity of bacterial SSI. However, the binding affinity (expressed as the dissociation constant [Kd ]) of choanepin9 measured via microscale thermophoresis was 21 nM, whereas that for bacterial SSI is 34 nM. The trend of binding and inhibitory activity suggests that the two inhibitors exhibit different inhibitory mechanisms for subtilisin protease. Interestingly, choanepin9 was identified as a monomer in studies in vitro, whereas bacterial SSI is a homodimer. Based on these observations, we constructed a monomeric bacterial SSI protein with decreased binding affinity to abrogate its inhibitory activity. By altering the reactive sites of choanepin9 deduced from the P1 and P4 sites of bacterial SSI, we reestablished that these residues in choanepins are also crucial for modulating inhibitory activity. These findings suggest that the fungal SSI evolved to target specific cognate proteases by altering the residues involved in inhibitory reactivity (reactive sites) and binding affinity (structural integrity). The function of fungal SSI proteins identified in this study provides not only a clue to fungal pathogenesis via protease inhibition but also a template for the design of novel serine protease inhibitors.IMPORTANCE Until recently, Streptomyces subtilisin inhibitors (SSI) were reported and characterized only in bacteria. We found SSI-like domains in a plant-pathogenic fungus, Choanephora cucurbitarum KUS-F28377, which contains 11 sequentially diverged SSI-like domains. None of these fungal SSI-like domains were functionally characterized before. The active form of fungal SSI-like protein is a monomer, in contrast to the homodimeric bacterial SSI. We constructed a synthetic monomer of bacterial SSI to demonstrate the modulation of its activity based on structural integrity and not reactive sites. Our results suggest the duplication and divergence of SSI-like domains of C. cucurbitarum within the genome to inhibit various cognate proteases during evolution by modulating both binding and reactivity. The molecular functional characterization of fungal SSI-like domains will be useful in understanding their biological role and future biotechnological applications.


Subject(s)
Fungal Proteins/genetics , Fungal Proteins/metabolism , Mucorales/genetics , Subtilisin/antagonists & inhibitors , Amino Acid Sequence , Mucorales/metabolism , Phylogeny , Protein Domains
2.
Int J Biol Macromol ; 163: 1162-1167, 2020 Nov 15.
Article in English | MEDLINE | ID: mdl-32673721

ABSTRACT

The application of inhibitors facilitates the stable preservation of enzyme in liquid detergent by mitigating the proteolytic activity of subtilisin. The conventionally used subtilisin inhibitors such as boric acid pose a threat to the environment and human health. Thus, the formulation of novel subtilisin inhibitors demands immediate attention. In the current study, we have screened the peptide inhibitors for subtilisin by employing the in vitro mRNA display technique. It is a sensitive screening technique with a high library capacity. The affinity screening was performed between the biotin-modified subtilisin immobilized on the streptavidin magnetic beads and the cDNA-mRNA-peptide fusion molecular library acquired from the in vitro translation and reverse transcription. The candidate peptides with high affinity were obtained after multiple rounds of screening. Furthermore, the inhibitory effect was evaluated, showing that some candidate peptides had inhibitory effects, but the isothermal titration calorimetry and time dependent experiments ultimately proved that these candidate peptides were not stable inhibitors. However, the in vitro mRNA display method explored in this study can be used as a preliminary screening method to provide candidate peptides for the screening of subtilisin inhibitors.


Subject(s)
Peptides/chemistry , Peptides/genetics , RNA/genetics , Subtilisin/antagonists & inhibitors , Subtilisin/genetics , Biotin , Humans , In Vitro Techniques/methods , Mass Screening/methods , Peptide Library , Protein Biosynthesis/genetics , RNA, Messenger/genetics , Reverse Transcription/genetics , Streptavidin/genetics
3.
Fish Shellfish Immunol ; 68: 341-348, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28743625

ABSTRACT

The single WAP domain-containing protein (SWD) is a type III crustin antimicrobial peptide whose function is to defense the host animal against the bacterial infection by means of antimicrobial and antiproteinase activities. A study of SWD from Litopenaeus vannamei (LvSWD) is reported herein about its activities and function against bacteria, particularly the AHPND-inducing Vibrio parahaemolyticus (VPAHPND) that causes acute hepatopancreatic necrosis disease (AHPND). The LvSWD is mainly synthesized in hemocytes and up-regulated in response to VPAHPND infection. Over-expressed mature recombinant LvSWD (rLvSWD) and its WAP domain (rLvSWD-WAP) are able to strongly inhibit subtilisin but not trypsin, chymotrypsin and elastase. The rLvSWD inhibits subtilisin with the inhibition constant (Ki) of 14.3 nM. However, only rLvSWD exhibited antimicrobial activity against both Gram-positive and Gram-negative bacteria. Unlike the rLvSWD, the rLvSWD-WAP does not possess antimicrobial activity. Therefore, the killing effect of rLvSWD on VPAHPND and Bacillus megaterium was studied. The MIC of 30 µM against VPAHPND is bactericidal whereas the MIC against B. megaterium is not. With four times the MIC of rLvSWD, the VPAHPND-treated post larval shrimp are able to survive longer with 50% survival rate as long as 78 h as compared to 36 h of the infected shrimp without rLvSWD. The antimicrobial activity of LvSWD against the VPAHPND infection suggests its potential application for disease control in aquaculture.


Subject(s)
Arthropod Proteins/immunology , Arthropod Proteins/pharmacology , Immunity, Innate/genetics , Penaeidae/immunology , Penaeidae/microbiology , Subtilisin/antagonists & inhibitors , Vibrio parahaemolyticus/drug effects , Amino Acid Sequence , Animals , Anti-Infective Agents/pharmacology , Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/immunology , Antimicrobial Cationic Peptides/pharmacology , Arthropod Proteins/chemistry , Arthropod Proteins/genetics , Base Sequence , Enzyme Activation/drug effects , Penaeidae/genetics , Subtilisin/metabolism
4.
J Biol Chem ; 292(37): 15161-15179, 2017 09 15.
Article in English | MEDLINE | ID: mdl-28684417

ABSTRACT

Blood coagulation is a finely regulated physiological process culminating with the factor Xa (FXa)-mediated conversion of the prothrombin (ProT) zymogen to active α-thrombin (αT). In the prothrombinase complex on the platelet surface, FXa cleaves ProT at Arg-271, generating the inactive precursor prethrombin-2 (Pre2), which is further attacked at Arg-320-Ile-321 to yield mature αT. Whereas the mechanism of physiological ProT activation has been elucidated in great detail, little is known about the role of bacterial proteases, possibly released in the bloodstream during infection, in inducing blood coagulation by direct proteolytic ProT activation. This knowledge gap is particularly concerning, as bacterial infections are frequently complicated by severe coagulopathies. Here, we show that addition of subtilisin (50 nm to 2 µm), a serine protease secreted by the non-pathogenic bacterium Bacillus subtilis, induces plasma clotting by proteolytically converting ProT into active σPre2, a nicked Pre2 derivative with a single cleaved Ala-470-Asn-471 bond. Notably, we found that this non-canonical cleavage at Ala-470-Asn-471 is instrumental for the onset of catalysis in σPre2, which was, however, reduced about 100-200-fold compared with αT. Of note, σPre2 could generate fibrin clots from fibrinogen, either in solution or in blood plasma, and could aggregate human platelets, either isolated or in whole blood. Our findings demonstrate that alternative cleavage of ProT by proteases, even by those secreted by non-virulent bacteria such as B. subtilis, can shift the delicate procoagulant-anticoagulant equilibrium toward thrombosis.


Subject(s)
Bacillus subtilis/enzymology , Bacterial Proteins/metabolism , Blood Coagulation , Models, Molecular , Platelet Aggregation , Prothrombin/agonists , Subtilisin/metabolism , Adult , Bacterial Proteins/antagonists & inhibitors , Blood Coagulation/drug effects , Catalytic Domain , Enzyme Activation/drug effects , Enzyme Stability/drug effects , Female , Humans , Male , Peptide Fragments/agonists , Peptide Fragments/chemistry , Peptide Fragments/genetics , Peptide Fragments/metabolism , Platelet Aggregation/drug effects , Protein Conformation , Protein Interaction Domains and Motifs , Proteolysis/drug effects , Prothrombin/chemistry , Prothrombin/genetics , Prothrombin/metabolism , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Serine Proteinase Inhibitors/pharmacology , Substrate Specificity , Subtilisin/antagonists & inhibitors , Thrombosis/etiology , Thrombosis/metabolism
5.
Colloids Surf B Biointerfaces ; 156: 382-387, 2017 Aug 01.
Article in English | MEDLINE | ID: mdl-28551572

ABSTRACT

The cyclic lipopeptide surfactin (SF) is one of the promising environmental friendly biosurfactants abundantly produced by microorganisms such as Bacillus subtilis. SF shows excellent surface properties at various pH, together with lower toxicity and higher biodegradability than commonly used petroleum-based surfactants. However, the effect of the dissociation degree of SF on self-assembly is still incompletely understood, even though two acidic amino acid residues (Asp and Glu) are known to influence eventual surface and biological functions. Here, we report changes in the secondary structure of SF induced by increased pH, and the effect on protease activity. We found that the ß-sheet and ß-turn formation of SF are significantly enhanced through increased dissociation of Asp and Glu as revealed by a titration experiment of SF solution to estimate apparent pK1 and pK2 values together with circular dichroism spectroscopy. We also studied the activity of the common detergent enzyme subtilisin in SF solution at above its pK2 (pH 7.6) to understand the role of the dissociation degree in the interaction with the protein. The mixing of SF having a unique cyclic topological feature with subtilisin suppressed the decrease in protease activity observed in the presence of synthetic surfactants such as sodium dodecyl sulfate and polyoxyethylene alkyl ether. Thus, SF has great potential for use in laundry detergent formulations, to improve the stability and reliability of detergent enzymes.


Subject(s)
Lipopeptides/pharmacology , Peptides, Cyclic/pharmacology , Subtilisin/metabolism , Bacillus subtilis/enzymology , Enzyme Activation/drug effects , Hydrogen-Ion Concentration , Lipopeptides/chemistry , Peptides, Cyclic/chemistry , Polyethylene Glycols/pharmacology , Protein Conformation , Sodium Dodecyl Sulfate/pharmacology , Subtilisin/antagonists & inhibitors , Subtilisin/chemistry
6.
Biotechnol Lett ; 39(1): 141-148, 2017 Jan.
Article in English | MEDLINE | ID: mdl-27752792

ABSTRACT

OBJECTIVES: To clone and characterize a novel bi-functional α-amylase/subtilisin inhibitor (LASI) from the rhizome of Ligusticum chuanxiong, a traditional Chinese medicine. RESULTS: The LASI showed strong homology with members of the Kunitz trypsin inhibitor family. Its putative amino acid sequence has a 40 % identity with that of the α-amylase/subtilisin inhibitor from rice. LASI gene without signal peptide was expressed in E. coli Rosetta. After purification, the recombinant LASI protein was inhibitory against not only α-amylase from porcine pancreas, Helicoverpa armigera, Spodoptera litura and Plutella xylostella, but also subtilisin A, but not against trypsin or chymotrypsin. In addition, the expression level of LASI in rhizome was higher than that in leaf and LASI expression was enhanced by salt, chilling and drought treatment. CONCLUSIONS: This is the first member of the Kunitz-protease inhibitor family identified in traditional Chinese medicine and it might be involved in the plant defense responses against lepidopterous pests, microorganisms and abiotic stresses.


Subject(s)
Enzyme Inhibitors/metabolism , Ligusticum/metabolism , Rhizome/metabolism , Subtilisin/antagonists & inhibitors , alpha-Amylases/antagonists & inhibitors , Cloning, Molecular , Enzyme Inhibitors/pharmacology
8.
Angew Chem Int Ed Engl ; 55(32): 9398-401, 2016 08 01.
Article in English | MEDLINE | ID: mdl-27336908

ABSTRACT

Microviridins are a family of ribosomally synthesized and post-translationally modified peptides with a highly unusual architecture featuring non-canonical lactone as well as lactam rings. Individual variants specifically inhibit different types of serine proteases. Here we have established an efficient in vitro reconstitution approach based on two ATP-grasp ligases that were constitutively activated using covalently attached leader peptides and a GNAT-type N-acetyltransferase. The method facilitates the efficient in vitro one-pot transformation of microviridin core peptides to mature microviridins. The engineering potential of the chemo-enzymatic technology was demonstrated for two synthetic peptide libraries that were used to screen and optimize microviridin variants targeting the serine proteases trypsin and subtilisin. Successive analysis of intermediates revealed distinct structure-activity relationships for respective target proteases.


Subject(s)
Peptide Library , Peptides, Cyclic/pharmacology , Serine Proteinase Inhibitors/pharmacology , Subtilisin/antagonists & inhibitors , Trypsin/metabolism , Biosynthetic Pathways , Peptides, Cyclic/biosynthesis , Peptides, Cyclic/chemistry , Serine Proteinase Inhibitors/biosynthesis , Serine Proteinase Inhibitors/chemistry , Subtilisin/metabolism
9.
Plant Cell Rep ; 34(8): 1443-57, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25941157

ABSTRACT

KEY MESSAGE: The 2-kb ZmCI - 1B promoter is active in the root and embryo and induced by wounding in maize and the 220-bp 5'-deleted segment maybe the minimal promoter. The subtilisin-chymotrypsin inhibitor gene, CI-1B of Zea mays (ZmCI-1B), has been suggested to induce the maize defense system to resist insect attack. Real-time RT-PCR showed that ZmCI-1B gene exhibited especially high expression in roots and embryos. The 2-kb full-length promoter of ZmCI-1B gene was isolated from the maize genome and used to drive expression of a beta-glucuronidase (GUS) reporter gene for transient expression and stable expression analysis in maize. The results of GUS histochemical staining in transgenic maize plants revealed that the ZmCI-1B promoter induced GUS expression preferentially in roots and embryos and in response to wounding. A series of 5'-deleted segments of the ZmCI-1B promoter were cloned individually to drive GUS expression for further analysis. Deletion analysis combined with the histochemical staining of transgenic tobacco plants revealed 220-bp segment could drive GUS in a tissue-specific and wounding-induced expression in tobacco; thus, it maybe the minimally active promoter of ZmCI-1B gene. Furthermore, it revealed that the ZmCI-1B promoter contained tissue-specific and wounding-induced elements.


Subject(s)
Nicotiana/genetics , Plant Proteins/genetics , Plants, Genetically Modified/genetics , Promoter Regions, Genetic/genetics , Zea mays/genetics , Chymotrypsin/antagonists & inhibitors , Chymotrypsin/genetics , Gene Expression Regulation, Plant/genetics , Gene Expression Regulation, Plant/physiology , Glucuronidase/biosynthesis , Glucuronidase/physiology , Plant Proteins/physiology , Plant Roots/physiology , Plants, Genetically Modified/physiology , Promoter Regions, Genetic/physiology , Real-Time Polymerase Chain Reaction , Subtilisin/antagonists & inhibitors , Subtilisin/genetics , Nicotiana/physiology , Zea mays/physiology
10.
J Enzyme Inhib Med Chem ; 30(6): 867-73, 2015 Dec.
Article in English | MEDLINE | ID: mdl-25643757

ABSTRACT

Can one infer the amino acids of the enzymes that are responsible for the stability or the level of the catalytic activity by computationally experimenting on the inhibited enzyme in the enzyme-inhibitor complex? In this article, we answer this question positively both by designing molecular dynamics simulations and by devising coarse-grained methodologies on the subtilisin serine protease. Both methodologies are based on the cross-correlations of the fluctuations of the residues, obtained either by monitoring the trajectories from the simulation or by constructing the inverse Laplacian of the elastic network model, of the complex. A perturbation scanning is applied to the complex using these correlations. The results indicate that the two methods almost point out the same regions on the flexible of the enzyme. These regions are: (i) 50-61, (ii) 155-164 and (iii) 192-194, all of which are designated to be important by experimental studies in the literature.


Subject(s)
Molecular Dynamics Simulation , Subtilisin/chemistry , Subtilisin/metabolism , Enzyme Stability , Subtilisin/antagonists & inhibitors
11.
Antiviral Res ; 115: 94-104, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25573299

ABSTRACT

Worldwide, approximately 170 million individuals are afflicted with chronic hepatitis C virus (HCV) infection. To prevent the development of inherent diseases such as cirrhosis and hepatocellular carcinoma, tremendous efforts have been made, leading to the development of promising new treatments. However, their efficiency is still dependent on the viral genotype. Additionally, these treatments that target the virus directly can trigger the emergence of resistant variants. In a previous study, we have demonstrated that a long-term (72h) inhibition of SKI-1/S1P, a master lipogenic pathway regulator through activation of SREBP, resulted in impaired HCV genome replication and infectious virion secretion. In the present study, we sought to investigate the antiviral effect of the SKI-1/S1P small molecule inhibitor PF-429242 at the early steps of the HCV lifecycle. Our results indicate a very potent antiviral effect of the inhibitor early in the viral lifecycle and that the overall action of the compound relies on two different contributions. The first one is SREBP/SKI-1/S1P dependent and involves LDLR and NPC1L1 proteins, while the second one is SREBP independent. Overall, our study confirms that SKI-1/S1P is a relevant target to impair HCV infection and that PF-429242 could be a promising candidate in the field of HCV infection treatment.


Subject(s)
Antiviral Agents/pharmacology , Hepacivirus/drug effects , Hepatitis C/drug therapy , Pyrrolidines/pharmacology , Cell Line, Tumor , Gene Expression Regulation, Viral/drug effects , Genotype , Hepacivirus/genetics , Hepacivirus/growth & development , Humans , Membrane Proteins/metabolism , Membrane Transport Proteins , Proprotein Convertase 9 , Proprotein Convertases/antagonists & inhibitors , Proprotein Convertases/metabolism , Receptors, LDL/metabolism , Serine Endopeptidases/metabolism , Subtilisin/antagonists & inhibitors , Subtilisin/metabolism , Virion/metabolism , Virus Replication/drug effects
12.
J Biol Chem ; 290(1): 658-70, 2015 Jan 02.
Article in English | MEDLINE | ID: mdl-25389290

ABSTRACT

All prokaryotic genes encoding putative serpins identified to date are found in environmental and commensal microorganisms, and only very few prokaryotic serpins have been investigated from a mechanistic standpoint. Herein, we characterized a novel serpin (miropin) from the human pathogen Tannerella forsythia, a bacterium implicated in initiation and progression of human periodontitis. In contrast to other serpins, miropin efficiently inhibited a broad range of proteases (neutrophil and pancreatic elastases, cathepsin G, subtilisin, and trypsin) with a stoichiometry of inhibition of around 3 and second-order association rate constants that ranged from 2.7 × 10(4) (cathepsin G) to 7.1 × 10(5) m(-1)s(-1) (subtilisin). Inhibition was associated with the formation of complexes that were stable during SDS-PAGE. The unusually broad specificity of miropin for target proteases is achieved through different active sites within the reactive center loop upstream of the P1-P1' site, which was predicted from an alignment of the primary structure of miropin with those of well studied human and prokaryotic serpins. Thus, miropin is unique among inhibitory serpins, and it has apparently evolved the ability to inhibit a multitude of proteases at the expense of a high stoichiometry of inhibition and a low association rate constant. These characteristics suggest that miropin arose as an adaptation to the highly proteolytic environment of subgingival plaque, which is exposed continually to an array of host proteases in the inflammatory exudate. In such an environment, miropin may function as an important virulence factor by protecting bacterium from the destructive activity of neutrophil serine proteases. Alternatively, it may act as a housekeeping protein that regulates the activity of endogenous T. forsythia serine proteases.


Subject(s)
Bacterial Proteins/chemistry , Bacteroidetes/chemistry , Serine Proteinase Inhibitors/chemistry , Serpins/chemistry , Amino Acid Sequence , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Catalytic Domain , Cathepsin G/antagonists & inhibitors , Cathepsin G/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Gene Expression , Humans , Kinetics , Leukocyte Elastase/antagonists & inhibitors , Leukocyte Elastase/metabolism , Molecular Sequence Data , Periodontal Pocket/microbiology , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Sequence Alignment , Serine Proteinase Inhibitors/genetics , Serine Proteinase Inhibitors/metabolism , Serpins/genetics , Serpins/metabolism , Substrate Specificity , Subtilisin/antagonists & inhibitors , Subtilisin/metabolism , Thermodynamics , Trypsin/metabolism
13.
PLoS One ; 9(10): e111416, 2014.
Article in English | MEDLINE | ID: mdl-25360755

ABSTRACT

The proteolysis kinetics of intact proteins by nonspecific proteases provides valuable information on transient partial unfolding of proteins under native conditions. Native-state proteolysis is an approach to utilize the proteolysis kinetics to assess the energetics of partial unfolding in a quantitative manner. In native-state proteolysis, folded proteins are incubated with nonspecific proteases, and the rate of proteolysis is determined from the disappearance of the intact protein. We report here that proteolysis of intact proteins by nonspecific proteases, thermolysin and subtilisin deviates from first-order kinetics. First-order kinetics has been assumed for the analysis of native-state proteolysis. By analyzing the kinetics of proteolysis with varying concentrations of substrate proteins and also with cleavage products, we found that the deviation from first-order kinetics results from product inhibition. A kinetic model including competitive product inhibition agrees well with the proteolysis time course and allows us to determine the uninhibited rate constant for proteolysis as well as the apparent inhibition constant. Our finding suggests that the likelihood of product inhibition must be considered for quantitative assessment of proteolysis kinetics.


Subject(s)
Models, Biological , Proteolysis , Kinetics , Ribonuclease H/metabolism , Subtilisin/antagonists & inhibitors , Subtilisin/metabolism , Tetrahydrofolate Dehydrogenase/metabolism , Thermolysin/antagonists & inhibitors , Thermolysin/metabolism
14.
PLoS One ; 9(9): e106936, 2014.
Article in English | MEDLINE | ID: mdl-25233114

ABSTRACT

Purification of suitable quantity of homogenous protein is very often the bottleneck in protein structural studies. Overexpression of a desired gene and attachment of enzymatically cleavable affinity tags to the protein of interest made a breakthrough in this field. Here we describe the structure of Galleria mellonella silk proteinase inhibitor 2 (GmSPI-2) determined both by X-ray diffraction and NMR spectroscopy methods. GmSPI-2 was purified using a new method consisting in non-enzymatic His-tag removal based on a highly specific peptide bond cleavage reaction assisted by Ni(II) ions. The X-ray crystal structure of GmSPI-2 was refined against diffraction data extending to 0.98 Å resolution measured at 100 K using synchrotron radiation. Anisotropic refinement with the removal of stereochemical restraints for the well-ordered parts of the structure converged with R factor of 10.57% and Rfree of 12.91%. The 3D structure of GmSPI-2 protein in solution was solved on the basis of 503 distance constraints, 10 hydrogen bonds and 26 torsion angle restraints. It exhibits good geometry and side-chain packing parameters. The models of the protein structure obtained by X-ray diffraction and NMR spectroscopy are very similar to each other and reveal the same ß2αß fold characteristic for Kazal-family serine proteinase inhibitors.


Subject(s)
Insect Proteins/ultrastructure , Moths/enzymology , Recombinant Fusion Proteins/ultrastructure , Affinity Labels/chemistry , Amino Acid Sequence , Animals , Computer Simulation , Crystallography, X-Ray/methods , Endopeptidase K/antagonists & inhibitors , Insect Proteins/analysis , Molecular Sequence Data , Nuclear Magnetic Resonance, Biomolecular/methods , Protein Structure, Tertiary , Recombinant Fusion Proteins/analysis , Sequence Alignment , Subtilisin/antagonists & inhibitors
15.
Toxins (Basel) ; 6(3): 850-68, 2014 Feb 28.
Article in English | MEDLINE | ID: mdl-24590383

ABSTRACT

Elapid snake venom is a highly valuable, but till now mainly unexplored, source of pharmacologically important peptides. We analyzed the peptide fractions with molecular masses up to 10 kDa of two elapid snake venoms-that of the African cobra, N. m. mossambica (genus Naja), and the Peninsula tiger snake, N. scutatus, from Kangaroo Island (genus Notechis). A combination of chromatographic methods was used to isolate the peptides, which were characterized by combining complimentary mass spectrometric techniques. Comparative analysis of the peptide compositions of two venoms showed specificity at the genus level. Three-finger (3-F) cytotoxins, bradykinin-potentiating peptides (BPPs) and a bradykinin inhibitor were isolated from the Naja venom. 3-F neurotoxins, Kunitz/basic pancreatic trypsin inhibitor (BPTI)-type inhibitors and a natriuretic peptide were identified in the N. venom. The inhibiting activity of the peptides was confirmed in vitro with a selected array of proteases. Cytotoxin 1 (P01467) from the Naja venom might be involved in the disturbance of cellular processes by inhibiting the cell 20S-proteasome. A high degree of similarity between BPPs from elapid and viperid snake venoms was observed, suggesting that these molecules play a key role in snake venoms and also indicating that these peptides were recruited into the snake venom prior to the evolutionary divergence of the snakes.


Subject(s)
Elapid Venoms/chemistry , Elapidae , Peptides/isolation & purification , Protease Inhibitors/isolation & purification , Amino Acid Sequence , Animals , Bradykinin/antagonists & inhibitors , Chromatography, Gel , Chromatography, Liquid , Chymotrypsin/antagonists & inhibitors , Electrophoresis, Polyacrylamide Gel , Molecular Sequence Data , Peptides/pharmacology , Peptidyl-Dipeptidase A/metabolism , Protease Inhibitors/pharmacology , Sequence Alignment , Spectrometry, Mass, Electrospray Ionization , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Subtilisin/antagonists & inhibitors , Trypsin/metabolism
16.
Appl Biochem Biotechnol ; 171(1): 209-24, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23824530

ABSTRACT

Several recombinant derivatives of serine protease inhibitor called silk protease inhibitor 2 (SPI2), which is a silk component in Galleria mellonella (Lepidoptera, Insecta), were prepared in the expression vector Pichia pastoris. Both the native and the recombinant protease inhibitors were highly active against subtilisin and proteinase K. The synthetic SPI2 gene with Ala codon in the P1 position was fused with mGFP-5 to facilitate detection of the transgene and its protein product. A construct of the fusion gene with plant regulatory elements (promoter 35S and terminator OCS) was inserted into the binary vector pRD400. The final construct was introduced into Agrobacterium tumefaciens that was then used for genetic transformation of the potato variety Velox. The transgene expression was monitored with the aid of ELISA employing polyclonal antibody against natural SPI2. In vitro tests showed increased resistance to the late blight Phytophthora infestans in several transformed lines. No effect was seen on the growth, mortality, life span or reproduction of Spodoptera littoralis (Lepidoptera, Insecta) caterpillars, while feeding on transformed potato plants expressing the fusion protein, indicating that the transformed potatoes may be harmless to non-target organisms.


Subject(s)
Genetic Engineering/methods , Insect Proteins/genetics , Lepidoptera/genetics , Solanum tuberosum/genetics , Animals , Disease Resistance/genetics , Extracellular Space/enzymology , Gene Expression , Genetic Engineering/adverse effects , Phytophthora infestans/physiology , Pichia/genetics , Plant Diseases/parasitology , Plants, Genetically Modified , Solanum tuberosum/cytology , Solanum tuberosum/immunology , Solanum tuberosum/parasitology , Spodoptera , Subtilisin/antagonists & inhibitors , Subtilisin/metabolism , Transformation, Genetic
17.
Appl Environ Microbiol ; 79(19): 6173-5, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23872568

ABSTRACT

Clostridium thermocellum encodes a cellulosomal, modular, and thermostable serine protease inhibitor (serpin), PinA. PinA stability but not inhibitory activity is affected by the Fn(III) and Doc(I) domains, and PinA is a broad inhibitor of subtilisin-like proteases and may play a key role in protecting the cellulosome from protease attack.


Subject(s)
Cellulase/metabolism , Clostridium thermocellum/enzymology , Multienzyme Complexes/metabolism , Serpins/metabolism , Subtilisin/antagonists & inhibitors , Protein Stability , Serpins/chemistry
18.
Dev Comp Immunol ; 41(2): 110-9, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23660411

ABSTRACT

Serpin or serine proteinase inhibitor is a family of protease inhibitors that are involved in controlling the proteolytic cascade in various biological processes. In shrimp, several serpins have been identified but only a few have been characterized. Herein, the PmSERPIN3 gene identified from Penaeus monodon EST database was studied. By using the 5'- and 3'-Rapid Amplification of cDNA Ends (RACE) techniques, the full-length of PmSERPIN3 cDNA was obtained. The cDNA contained an open reading frame of 1233 bp encoding for 410 amino acid residue protein. Genome sequence analysis revealed that the PmSERPIN3 was an intronless gene. RT-PCR analysis revealed that it was constitutively expressed in all developmental stages, all shrimp tissues tested, and upon pathogen infections. The recombinant mature PmSERPIN3 protein (rPmSERPIN3) produced in Escherichia coli exhibited inhibitory activity against subtilisin. The rPmSERPIN3 also inhibited the shrimp prophenoloxidase system activation in vitro. Injecting the rPmSERPIN3 along with Vibrio harveyi into the shrimp decreased the clearance rate of bacteria in the hemolymph. Potentially, the PmSERPIN3 functions as a regulator of the proPO activating system.


Subject(s)
Arthropod Proteins/genetics , Catechol Oxidase/metabolism , Enzyme Precursors/metabolism , Gene Expression Profiling , Penaeidae/genetics , Serine Proteinase Inhibitors/genetics , Amino Acid Sequence , Animals , Arthropod Proteins/classification , Arthropod Proteins/pharmacology , Base Sequence , Catechol Oxidase/antagonists & inhibitors , Enzyme Precursors/antagonists & inhibitors , Hemocytes/metabolism , Hemolymph/drug effects , Hemolymph/microbiology , Molecular Sequence Data , Penaeidae/microbiology , Penaeidae/virology , Phylogeny , Recombinant Proteins/pharmacology , Reverse Transcriptase Polymerase Chain Reaction , Serine Proteinase Inhibitors/classification , Serine Proteinase Inhibitors/pharmacology , Subtilisin/antagonists & inhibitors , Subtilisin/metabolism
19.
Gene ; 514(2): 99-104, 2013 Feb 10.
Article in English | MEDLINE | ID: mdl-23200819

ABSTRACT

A 255-bp cDNA encoding an 84-amino acid residue (aa) precursor protein containing 8 half-cysteines was cloned from the skin of the frog, Ceratophrys calcarata. By sequence comparison and signal peptide prediction, the precursor was predicted to release a 63-aa mature peptide with amino acid sequence, NVTPATKPTPSKPGYCRVMDELILCPDPPLSKDLCKNDSDCPGAQKCCYRTCIMQCLPPIFRE. The mature was named ceratoxin. Ceratoxin shares significant sequence similarity with the toxin family of waprins containing the whey acidic protein-type (WAP) four-disulfide core domain found in snake venoms. Antimicrobial and trypsin-inhibitory abilities of recombinant ceratoxin were tested. Recombinant ceratoxin showed strong antimicrobial activities against wide spectrum of microorganisms including Gram-negative and Gram-positive bacteria and fungi. It had no serine protease-inhibitory activity. The current results suggested that the snake venom-like waprin with antimicrobial activities in the frog skin plays a role in innate immunity.


Subject(s)
Anti-Infective Agents/metabolism , Anura/metabolism , Skin/metabolism , Toxins, Biological/metabolism , Amino Acid Sequence , Amphibian Venoms/genetics , Amphibian Venoms/metabolism , Amphibian Venoms/pharmacology , Animals , Anti-Infective Agents/chemistry , Anti-Infective Agents/pharmacology , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/metabolism , Antimicrobial Cationic Peptides/pharmacology , Anura/genetics , Base Sequence , Chymotrypsin/antagonists & inhibitors , Chymotrypsin/metabolism , Cloning, Molecular , DNA, Complementary/chemistry , DNA, Complementary/genetics , Electrophoresis, Polyacrylamide Gel , Erythrocytes/drug effects , Hemolysis , Microbial Sensitivity Tests , Molecular Sequence Data , Rabbits , Sequence Analysis, DNA , Sequence Homology, Amino Acid , Snake Venoms/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Staphylococcus aureus/drug effects , Staphylococcus aureus/growth & development , Substrate Specificity , Subtilisin/antagonists & inhibitors , Subtilisin/metabolism , Toxins, Biological/genetics , Toxins, Biological/pharmacology
20.
Plant Physiol ; 161(1): 97-107, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23150644

ABSTRACT

In Solanaceae, the self-incompatibility S-RNase and S-locus F-box interactions define self-pollen recognition and rejection in an S-specific manner. This interaction triggers a cascade of events involving other gene products unlinked to the S-locus that are crucial to the self-incompatibility response. To date, two essential pistil-modifier genes, 120K and High Top-Band (HT-B), have been identified in Nicotiana species. However, biochemistry and genetics indicate that additional modifier genes are required. We recently reported a Kunitz-type proteinase inhibitor, named NaStEP (for Nicotiana alata Stigma-Expressed Protein), that is highly expressed in the stigmas of self-incompatible Nicotiana species. Here, we report the proteinase inhibitor activity of NaStEP. NaStEP is taken up by both compatible and incompatible pollen tubes, but its suppression in Nicotiana spp. transgenic plants disrupts S-specific pollen rejection; therefore, NaStEP is a novel pistil-modifier gene. Furthermore, HT-B levels within the pollen tubes are reduced when NaStEP-suppressed pistils are pollinated with either compatible or incompatible pollen. In wild-type self-incompatible N. alata, in contrast, HT-B degradation occurs preferentially in compatible pollinations. Taken together, these data show that the presence of NaStEP is required for the stability of HT-B inside pollen tubes during the rejection response, but the underlying mechanism is currently unknown.


Subject(s)
Enzyme Inhibitors/metabolism , Nicotiana/metabolism , Peptides/metabolism , Plant Proteins/metabolism , Pollen Tube/metabolism , Self-Incompatibility in Flowering Plants , Amino Acid Sequence , Enzyme Activation , Genes, Plant , Molecular Sequence Data , Peptides/genetics , Plant Extracts/metabolism , Plant Proteins/genetics , Plants, Genetically Modified/genetics , Plants, Genetically Modified/metabolism , Pollen Tube/genetics , Pollination , Protein Interaction Mapping , Protein Stability , Protein Structure, Secondary , Proteolysis , RNA Interference , Subtilisin/antagonists & inhibitors , Nicotiana/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...